Health care reconciliation makers ramified with coverage and payment policies for drugs and devices have traditionally relied on randomized clinical trials (RCTs) for coverage and reimbursement decisions. However, a new report published in the September-October issue of Value in Health documents how decision makers are increasingly seeking evidence on "real-world" outcomes on which to base conclusions. [click link for full article]

More: - Read the rest here